Documente Academic
Documente Profesional
Documente Cultură
225
VITAMINS, TRACE MINERALS, AND
OTHER MICRONUTRIENTS
JOEL B. MASON
e47
Optimal Intake
Trace Elements
Fifteen trace elements have been identified as essential for health: iron, zinc,
copper, chromium, selenium, iodine, fluorine, manganese, molybdenum,
cobalt, nickel, tin, silicon, vanadium, and arsenic (see Table 225-3), but only
for the first 10 of these has compelling evidence indicated that they are essential nutrients in humans. Cobalt appears to be essential solely as a component
of vitamin B12, but an isolated deficiency state has never been described.
Deficiency syndromes for several of the essential trace elements were not
recognized until recently because of their exceedingly small requirements and
because of the ubiquitous nature of these elements in foodstuffs. Only under
exceptional circumstances, such as long-term reliance on total parenteral
nutrition lacking these elements, have some of the deficiency syndromes
been observed.
Evidence indicates that humans also have an absolute requirement for the
dietary component choline, which is a necessary precursor for acetylcholine
and phospholipids and is needed to sustain normal levels of biologic methylation. To date, the most significant adverse effect of dietary inadequacy has
been hepatic inflammation. Deficiency is nevertheless thought to be extremely
rare, although pregnancy, and particularly lactation, increases the apparent
requirement. Individuals whose long-term nutritional requirements are
solely derived from total parenteral nutrition appear to be susceptible to
choline deficiency. Both an RDA (425mg, women; 550mg, men) and a
TUL (3.5g) have now been established.
l-Carnitine is a dietary component that participates in fatty acid metabolism in mitochondria. Although no evidence exists for a dietary requirement
in children or adults, premature infants have very low stores of skeletal muscle
carnitine. Therefore, preterm infants receiving parenteral nutrition without
carnitine supplements appear to be the group at high risk for deficiency.
Parenteral supplementation of carnitine in such infants may increase serum
carnitine concentration and improve lipid tolerance, weight gain, and nitrogen retention.
Physiologic Factors
Stages of the life cycle frequently have a significant impact on the requirements of nutrients. Phases of rapid growth and development, such as in utero
development, infancy, adolescence, and pregnancy, are associated with
increases in the utilization of certain micronutrients on a per-kilogram basis.
Pregnancy
Requirements for most micronutrients are increased in pregnancy, but, proportionately, the observed increases in the maternal requirements for iron
and folate are particularly great and are related to the rapid proliferation of
the placental and fetal tissues. Periods of lactation are similarly associated
with remarkable increases in requirements; a lactating woman experiences
disproportionately large increases in her requirements for zinc and vitamins
A, E, and C to meet the metabolic demands incurred by milk production in
addition to the aforementioned needs observed in pregnancy.
Aside from its general role in supporting the rapid proliferation of placental
and fetal tissues, folate plays a specific role in the prevention of particular
birth defects. A 20 to 85% reduction in births complicated by neural tube
defects (NTDs, i.e., spina bifida and anencephaly) has been realized by providing women with a daily supplement of folic acid in the form of supplements or fortified foods. The optimal dose is not well defined, but 200 to
400g/day clearly affords a substantial degree of protection. Populations
with a high background rate of NTD births attain the largest reductions in
NTDs from supplemental folate. However, because the nascent neural tube
closes about day 20 after conception, the additional folate must be provided
before this time in order to be effective.
Infancy
Infancy carries particular vulnerabilities to specific micronutrient inadequacies. Healthy infants in the United States are typically supplemented with
vitamin K at birth and with iron and vitamin D during the course of the
first year because of their particular susceptibility to deficiencies of these
nutrients.
The ability to maintain adequate iron status from menarche through menopause is compromised in women by the additional losses incurred by
e48
Elderly Persons
DEFICIENCY [RDA*]
TOXICITY [TUL]
ASSESSMENT OF STATUS
FAT-SOLUBLE VITAMINS
Vitamin A
Vitamin D
e49
Vitamin K
TOXICITY [TUL]
ASSESSMENT OF STATUS
Depressed levels of vitamin
Plasma or serum concentration
K-dependent procoagulants
of -tocopherol is most
and potentiation of oral
commonly used. Additional
anticoagulants has been
accuracy is obtained by
reported, as has impaired
expressing this value per mg
WBC function. Doses of
of total plasma lipid. RBC
800mg/day have been
peroxide hemolysis test is
reported to increase slightly
not entirely specific but is a
the incidence of hemorrhagic
useful functional measure of
stroke. [1000mg]
the antioxidant potential of
cell membranes.
WATER-SOLUBLE VITAMINS
Thiamin
(vitamin B1)
Riboflavin
(vitamin B2)
e50
ASSESSMENT OF STATUS
Assessment of status is
problematic: blood levels of
vitamin not reliable.
Measurement of urinary
excretion of the niacin
metabolites,
N-methylnicotinamide and
2-pyridone, is thought to be
the most effective means of
assessment at present.
Vitamin B6
Folate
Niacin (vitamin
B3)
e51
Vitamin B12
Biotin
Pantothenic acid
*Recommended daily allowance (RDA) established for female (F) and male (M) adults by the U.S. Food and Nutrition Board, 1999-2001. In some instances, insufficient data exist to establish an RDA, in
which case the adequate intake (AI) established by the board is listed.
Tolerated upper intake (TUL) established for adults by the U.S. Food and Nutrition Board, 1999-2001.
PTH = parathyroid hormone; UVB = ultraviolet B.
e52
BIOCHEMISTRY AND
PHYSIOLOGY
Dietary chromium consists of both
inorganic and organic forms. Its
primary function in humans is to
potentiate insulin action. It
accomplishes this function as a
circulating complex called glucose
tolerance factor, thereby affecting
carbohydrate, fat, and protein
metabolism.
DEFICIENCY [RDA*]
TOXICITY [TUL]
ASSESSMENT OF STATUS
Toxicity after oral ingestion is
Plasma or serum concentration of
Deficiency in humans only described in
uncommon and seems confined to
chromium is a crude indicator
long-term total parenteral nutrition
gastric irritation. Airborne exposure
of chromium status; it appears
(TPN) patients receiving insufficient
may cause contact dermatitis,
to be meaningful when the
chromium. Hyperglycemia or impaired
eczema, skin ulcers, and
value is markedly above or
glucose tolerance occurs. Elevated
bronchogenic carcinoma. [no TUL
below the normal range.
plasma free fatty acid concentrations,
established]
neuropathy, encephalopathy, and
abnormalities in nitrogen metabolism
are also reported. Whether
supplemental chromium may improve
glucose tolerance in glucose-intolerant
individuals remains controversial. [F:
25g; M: 35g]
Copper
Fluorine
Iodine
Iron
e53
BIOCHEMISTRY AND
PHYSIOLOGY
A component of several
metalloenzymes. Most manganese
is in mitochondria, where it is a
component of manganese
superoxide dismutase.
DEFICIENCY [RDA*]
TOXICITY [TUL]
Manganese deficiency in the human has Toxicity by oral ingestion is unknown
not been conclusively demonstrated. It
in humans. Toxic inhalation causes
is said to cause hypocholesterolemia,
hallucinations, other alterations in
weight loss, hair and nail changes,
mentation, and extrapyramidal
movement disorders. [11mg]
dermatitis, and impaired synthesis of
vitamin Kdependent proteins. [F:
1.8mg; M: 2.3mg]
ASSESSMENT OF STATUS
Until the deficiency syndrome is
better defined, an appropriate
measure of status will be
difficult to develop.
Selenium
Zinc
*Recommended daily allowance (RDA) established for female (F) and male (M) adults by the U.S. Food and Nutrition Board, 1999-2001. In some instances, insufficient data exist to establish an RDA, in
which case the adequate intake (AI) established by the board is listed.
Tolerated upper limit (TUL) established for adults by the U.S. Food and Nutrition Board, 1999-2001.
PATHOPHYSIOLOGIC AND
PHARMACOLOGIC FACTORS
Diseases of the Gastrointestinal Tract
e54
Myriad rare inborn errors of metabolism have been described for vitamins
and minerals that impair an individuals ability to assimilate, utilize, or retain
a particular micronutrient (Chapter 212). Such defects are usually partial and
can often be overcome, to a certain extent, by administering doses of the
nutrient that are several degrees of magnitude greater than usually required.
Suspicion for such defects should be entertained if (1) a known defect exists
in the family, (2) a deficiency syndrome arises at birth or during infancy, or
(3) the deficiency syndrome is present despite adequate dietary intake and
the absence of any disease that would impair the ability to assimilate the
nutrient.
Medications
Toxins
Updating the definition of a micronutrient deficiency and establishing recommended daily intakes that are consistent with the most recent evidence
has proved difficult for several reasons. In some instances, a novel biochemical or physiologic role for a nutrient has been identified, but an appropriate
question that arises is whether optimization of such functions translates into
optimization of health. For example, providing supplemental vitamin E to
elderly individuals who are vitamin E replete enhances T-lymphocyte responsiveness; nevertheless, it is unclear whether this translates into diminished
infection rates. Another difficult problem pertains to the use of micronutrients in supraphysiologic quantities that exceed all conventional concepts of
Omeprazole
Vitamin B12
Sulfasalazine
Folate
Isoniazid
Pyridoxine
Impairs utilization of B6
Iron
Penicillamine
Zinc
what is necessary for health. Some micronutrients, when taken in such large
quantities, have effects on physiologic functions that impart apparent health
benefits. The ingestion of gram quantities of niacin to reduce low-density
lipoprotein (LDL) cholesterol is an example. Such physiologic effects are not
observed at more conventional levels of intake and are therefore usually considered pharmacologic effects of the nutrient. Thus, the determination of
optimal nutrient intake is highly dependent on which physiologic effect is
sought. Furthermore, if only a segment of the population will benefit from
supraphysiologic quantities of a nutrient, should dietary guidelines for the
remainder of the population be established according to this effect?
Determining an adequate level of intake implies the existence of a means
of measuring nutrient status. In seeking an appropriate measure of nutrient
status, the diversity of function often makes it difficult to decide which measurement is the most germane. Tobacco smoking, for example, diminishes
vitamin E levels in alveolar fluid but not in the serum. Thus, the concepts of
localized nutrient deficiencies and tissue-specific requirements add an additional level of complexity to the determination of nutrient status.
An example of the complexities that have arisen in redefining the criteria for
vitamin deficiencies and vitamin requirements is the water-soluble vitamin,
folate. In the past, guidelines regarding its necessary intake were straightforward because they were based solely on the prevention of megaloblastic
anemia. Measuring serum and erythrocyte folate concentrations were the
most common means of assessing status, and maintaining these levels within
accepted normative ranges provided assurance that folate status was adequate
to prevent anemia. However, degrees of deficiency that are insufficient to
cause anemia may still disturb normal biochemical and physiologic homeostasis and, in some instances, cause clinical disease. Clinical trials have demonstrated that women taking folic acid supplements at the time of conception
have a markedly lower chance of delivering a baby with an NTD compared
with women who are not folate supplemented but whose folate status falls
within a conventionally accepted range. This observation compelled the U.S.
government to mandate the fortification of flour, beginning in 1998. Present
recommendations are that women of childbearing age consume 400g/day
of folic acid in the form of supplements or fortified foods, although the doseresponse curve of this effect is ill defined.
Less than optimal intake of folate is also evidenced by an increase in
serum homocysteine, an amino acid that is normally metabolized by a folatedependent pathway. Before the federally mandated fortification of flour, the
median intake of folate among adults was one half of the present RDA, and
a substantial minority of Americans had significantly elevated serum homocysteine levels. Elevated homocysteine has been associated with the development of occlusive vascular disease and accelerated cognitive decline. In
randomized clinical trials, however, supplementation with folate, vitamin B12,
and vitamin B6 has shown no benefit against cardiovascular disease despite
its ability to lower homocysteine levels.1 Such supplementation also has no
clear benefit for cognitive function, except perhaps in patients with low baseline folate levels.2
A compelling body of observations in both humans and animals has demonstrated that habitually low consumption of folate is also associated with a
substantial increase in the risk for colorectal cancer, and perhaps cancers of
other organs such as those of the breast and pancreas. This inverse relationship is observed even when folate status (or dietary intake) falls within the
range of conventionally accepted normative values. This relationship has
further complicated the determination of what constitutes an optimal intake
of folate. The issue is further confounded by newer observations suggesting
that an exceptionally high intake of folate among those who unknowingly
harbor precancerous or cancerous lesions may paradoxically enhance the
progression of these neoplasms, thereby underscoring the potential for harm
produced by taking a nutrient outside of its physiologic window.
The most recent update of the U.S. RDA for folate, which occurred in
1998, raised the value from 200 to 400g/day, citing both the prevention of
anemia and optimization of serum homocysteine as criteria, and recommended that women capable of becoming pregnant consume an additional
400g/day in the form of supplements or fortified food. The issues surrounding the prevention of cardiovascular disease, cancer, and cognitive
decline were not incorporated into the 1998 determination because the
existing data at the time were thought to be inconclusive. However, it may
prove appropriate to integrate some of the knowledge surrounding these
issues in future revisions of the RDAs. The potential for toxicity, the criterion
e55
for which was primarily linked to its ability to mask vitamin B12 deficiency,
was dealt with by setting the TUL at 1000g/day of folic acid obtained from
supplements and fortified foods in addition to that obtained from natural
food sources (see Table 225-2).
The electronic version of this chapter describes two other instances that
exemplify how our expanding understanding of the biologic effects of micronutrients has complicated the process of determining guidelines for optimal
intake.3-5
Vitamins A, C, and E, as well as many of the carotenoids, are effective antioxidants. In addition, vitamins C and E and some of the carotenoids can
scavenge free radicals when these nutrients are taken in adequate quantities.
Oxidation and free radical damage have been implicated as important contributors to common degenerative illnesses such as atherosclerosis, cancer,
cataracts, and retinal degeneration. Clinical trials to test the efficacy of antioxidant supplements have shown no benefit and oftentimes harm,although
growing evidence indicates that the adverse effects of the large doses used in
many trials may have obscured the health benefits of these nutrients and that
populations with marginal antioxidant status may benefit from such supplements.3 Two large-scale clinical intervention trials with -carotene supplements conducted in the 1990s reported increased rates of lung cancer among
the recipients of the carotenoid. Subsequent mechanistic studies indicated
that the large doses administered (~30mg/day) result in asymmetrical cleavage of the carotenoid into unnatural products that antagonize normal signaling pathways in the lung epithelium, whereas lower supplemental doses
undergo symmetrical cleavage into two molecules of vitamin A, thereby protecting against neoplastic transformation.
LDL oxidized in vivo is atherogenic. Prevention of LDL oxidation, at least
in animal models, retards the process of atherogenesis. Supplementation of
human subjects with several times the RDA of -tocopherol, and perhaps
some of the other antioxidant micronutrients, is an effective means of preventing LDL oxidation. Human intervention trials with vitamin E or other
antioxidant nutrients, however, have generally been unable to demonstrate
clinical benefits in the reduction of cardiovascular events. There nevertheless
has been a sizeable reduction in cardiovascular events observed with vitamin
E supplementation among populations of patients who are under exceptional
oxidative stress, such as those with chronic renal failure and certain classes of
diabetes, suggesting that it is only among select groups of individuals that a
clinical benefit may be realized.
Nonalcoholic steatohepatitis (NASH) (Chapter 155), a disease that is
closely associated with features of the metabolic syndrome (Chapter 237),
can progress to cirrhosis in up to 15% of patients. Oxidative stress (as well as
insulin resistance) has been implicated as a key factor contributing to hepatic
injury in NASH. In a recent study of 247 nondiabetic patients with NASH,
vitamin E at a dose of 800IU daily for 96 weeks was associated with a significantly higher rate of improvement in NASH than placebo (43% vs. 19%, P =
.001).4
Epidemiologic studies indicate that occurrence of cancers of the oral
cavity, lung, esophagus, and stomach (and perhaps the colorectum) is
inversely related to dietary intake of fresh vegetables and fruits. Careful dissection of dietary data suggests that -carotene and vitamin E content are
strongly predictive components of these foodstuffs. High doses of vitamin A
and some of its synthetic analogues (e.g., 13-cis-retinoic acid) can effectively
reduce the recurrence of head and neck cancers, although hepatic toxicity is
sometimes a limiting factor in such cancer preventive therapy. Similarly, these
agents, as well as -carotene or vitamin E, when taken in large doses have
been shown significantly to promote the regression of oral leukoplakia, a
premalignant lesion. Daily supplementation with one to three times the U.S.
RDA of -carotene, selenium, and vitamin E has been shown to reduce the
incidence of adenocarcinoma of the stomach in a region of China where the
disease, as well as marginal vitamin status, is particularly prevalent. However,
as mentioned earlier, trials conducted in developed Western countries have
observed no diminution of lung cancer among smokers with daily supplementation of -carotene and vitamin E.
Epidemiologic associations also suggest an inverse relationship between
lens cataract or macular degeneration and the intake of vitamins C, E, and
-carotene. These common degenerative conditions of the eye are caused, at
least in part, by photo-oxidation. Some evidence in animal models indicates
that they can be retarded by supraphysiologic supplementation with vitamins
C or E. When tested under the conditions of a rigorously conducted
CLASSIC ROLE
Pro-vitamin A
NEW ROLE
Antioxidant, free radical
Niacin
NAD/NADP coenzyme
Folate
Hemopoietic factor
Diminishes homocysteinemia
Vitamin A
Vitamin D
Regulator of calcium
Vitamin B6
1. SEARCH Collaborative Group. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs
placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
JAMA. 2010;303:2486-2494.
2. Balk EM, Raman G, Tatsioni A, et al. Vitamin B6, B12, and folic acid supplementation and cognitive
function: a systematic review of randomized trials. Arch Intern Med. 2007;167:21-30.
3. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements
for primary and secondary prevention: systematic review and meta-analysis. JAMA.
2007;297:842-857.
4. Sanyal AJ, Chalasani N, Kowdley KV, et al, for the NASH CRN. Pioglitazone, vitamin E, or placebo
for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675-1685.
e56
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of
high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular
degeneration and vision loss: AREDS report no. 8 [erratum in Arch Ophthalmol. 2008;126:1251].
Arch Ophthalmol. 2001;119:1417-1436.
SUGGESTED READINGS
Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective
studies. JAMA. 2010;303:1077-1083. Systemic review with meta-analysis concluding that vitamin B6
intake and blood levels of the active form of vitamin B6 are inversely associated with the risk for colorectal
cancer.
Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and
vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab.
2011;96:53-58. Review concluding that the prevalence of vitamin D inadequacy in North America has
been overestimated.
Swanson AM, Hughey LC. Acute inpatient presentation of scurvy. Cutis. 2010;86:205-207. An unusual
case report.